Biotech Earnings Show Positive Rebound During Second Quarter

Mirasol, Feliza
July 2000
Chemical Market Reporter;07/24/2000, Vol. 258 Issue 4, p13
Trade Publication
Focuses on the earnings of biotechnology companies in the second quarter of 2000. Companies that reported growth in the quarter; Reasons for their revenue growth.


Related Articles

  • Biotech industry tries to recover from 2-year lull. Brower, Vicki // JNCI: Journal of the National Cancer Institute;3/5/2003, Vol. 95 Issue 5, p348 

    Looks at the financial performance of the biotechnology industry in the U.S. Role of the corporate side of biotechnology firms in the downward turn of the industry; Advantage of biotechnology drugs over technology products in terms of long-term investment; Effect of cancer drug approval on...

  • The Widening Gap Between Major and Emerging Biotech Players. Van Arnum, Patricia // Chemical Market Reporter;6/16/2003, Vol. 263 Issue 24, pFR2 

    Examines the widening revenue gap between major and emerging biotechnology companies. Sales of leading products in emerging biotech sector; Revenue for leading therapeutic proteins; Factors affecting the performance of the industry.

  • Public biotech 2000?the numbers. Lähteenmäki, Riku; Fletcher, Liz // Nature Biotechnology;May2001, Vol. 19 Issue 5, p407 

    Reports on the performance of biotechnology companies during the year 2000. Number of private biotechnology companies which became public companies; Statistics for total revenue, research and development spendings, profit and loss for the companies in the duration; Names of the top 10...

  • Bad reaction.  // Crain's New York Business;04/05/99, Vol. 15 Issue 14, p42 

    Reports on the financial performance of ImClone Systems Inc., a New York City-based biotechnology company, for 1998.

  • Zymetx reports net loss for fourth quarter.  // Biotech Financial Reports;Oct99, p1 

    Reports on Oklahoma City, Oklahoma-based viral management company Zymetx Inc.'s posting of financial results for the fourth quarter and fiscal year ending June 30, 1999. Total net loss for the quarter; Total revenues for the quarter; Total operating expenses; Development of strategic...

  • Biovail reports record 1999 4th qtr/year-end results.  // Biotech Financial Reports;Apr2000, p2 

    Reports that Toronto, Ontario-based biotechnology company Biovail Corp. International has announced record earnings during the fourth quarter of 1999. Percentage increase in the company's earnings during the fourth quarter of 1999 as compared to that of the same period in 1998; Net income and...

  • Lifecell reports 1999 product sales increase 64% over 1998.  // Biotech Financial Reports;Apr2000, p3 

    Reports that Branchburg, New Jersey-based biotechnology company LifeCell Corp. has announced a product sales increase in 1999. Percentage increase in the company's sales revenues in 1999 as compared to that of 1998; Factors attributing to the strong sales performance of the company during the...

  • BIOPOOL/XTRANA REPORTS 11% SALES INCREASE AND NET LOSS.  // Biotech Financial Reports;May2001, p1 

    Reports on the increased earnings of Biopool International Inc./Xtrana for the fiscal year ended December 31, 2000. Impact of the increased earnings on the company's stock prices; Plans by the company to expand its biotechnology business.

  • EMBREX REPORTS REVENUE INCREASES FOR 4TH QTR/YEAR 2000.  // Biotech Financial Reports;May2001, p4 

    Reports on the increased earnings of the biotechnology business of Embrex Inc. for the fiscal year ended December 31, 2000. Comparison with earnings for the same period in 1999; Factors attributed to the increase.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics